Kiniksa Pharmaceuticals International, plc Restricted Cash, Current
Kiniksa Pharmaceuticals International, plc (KNSA) had Restricted Cash, Current of $0 as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2024-02-28
- 2023-12-31: Restricted Cash, Current $0.00.
- 2022-12-31: Restricted Cash, Current $0.00.
- 2021-12-31: Restricted Cash, Current $0.00.
- 2021-09-30: Restricted Cash, Current $0.00.
| Period end | Restricted Cash, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 |
| 2021-06-30 | $210.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $210.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $210.00K 10-K · filed 2022-02-24 |
| 2018-06-30 | $263.00K 10-Q · filed 2018-08-06 |
| 2017-12-31 | $105.00K 10-K · filed 2019-03-12 |